- JP-listed companies
- SUZUKEN CO.,LTD.
- Financials
- Net income margin (%)
SUZUKEN CO.,LTD. (9987)
Market cap
¥437.6B
P/E ratio
13.3x
Suzuken distributes prescription drugs, medical devices and diagnostic products to healthcare providers across Japan through a nationwide network of subsidiaries.
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 1.4 | +18.24% |
| Mar 31, 2024 | 1.2 | +38.34% |
| Mar 31, 2023 | 0.9 | +35.60% |
| Mar 31, 2022 | 0.6 | +72.47% |
| Mar 31, 2021 | 0.4 | -70.58% |
| Mar 31, 2020 | 1.3 | -10.32% |
| Mar 31, 2019 | 1.4 | +59.73% |
| Mar 31, 2018 | 0.9 | -11.31% |
| Mar 31, 2017 | 1 | -22.79% |
| Mar 31, 2016 | 1.3 | +35.23% |
| Mar 31, 2015 | 1 | +27.90% |
| Mar 31, 2014 | 0.8 | +46.85% |
| Mar 31, 2013 | 0.5 | +513.72% |
| Mar 31, 2012 | 0.1 |